FDA Warning Letter Recipients: Where Are Their Claims Now?
This article was originally published in The Rose Sheet
A key component of FDA’s enforcement strategy in the cosmetics space is monitoring companies’ websites for overreaching product claims and issuing warning letters accordingly. Examination of past offenders’ current sites and updated claims offers potential visibility into language the agency will and will not tolerate when it comes to promoting skin-care benefits.
You may also be interested in...
The agency highlights claims for nine Be Natural Organics products – including statements about collagen production, cellular regeneration, hyperpigmentation reduction and eczema and acne treatment – in its recent warning letter to the company.
Prestige skin-care brand is positioning a range of StriVectin offerings as preventative against “tech neck,” or signs of aging that result from the repeated strain of checking mobile devices throughout the day. A comprehensive marketing campaign kicks off this fall with the potential to make anti-aging a more relevant category among Millennials.
Agency has been turning up the heat this summer on skin-care marketers, posting two more July warning letters issued to companies for use of unapproved drug claims. Firms that sell anti-aging serums, eye-area formulas or anything promoted as an “anti-wrinkle” solution should review their claims to ensure compliance.